Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 8,222 shares for $98,730.32

Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 8,222 shares for $98,730.32

ReutersReuters2026/08/31 23:07
  • Artiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 8,222 common shares on Aug. 27 at USD 12.01.
  • He also exercised employee stock options for 5,306 shares at USD 1.92 on the same day.
  • Directly held common shares totaled 142,047 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-377207), on August 31, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Did YouTube influencers turn everything into gold? GoPro (GPRO.US) surges another 60% pre-market, earnings losses can't stop the stock rally

GoPro (GPRO.US), the action camera manufacturer, continued its volatile stock movement, with its share price soaring again in pre-market trading on Tuesday after surging by 46% on Monday, at one point skyrocketing by 106%.

智通财经2026/09/01 12:41
Did YouTube influencers turn everything into gold? GoPro (GPRO.US) surges another 60% pre-market, earnings losses can't stop the stock rally